U 88999E
Latest Information Update: 10 Sep 1997
Price :
$50 *
At a glance
- Originator Pharmacia Corporation
- Developer Nonindustrial source; Pharmacia Corporation
- Class Antihypertensives
- Mechanism of Action Calcium channel antagonists; Endothelin receptor antagonists; Lipid peroxidation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cerebrovascular disorders
Most Recent Events
- 10 Sep 1997 No-Development-Reported for Cerebrovascular disorders in Japan (Unknown route)
- 10 Sep 1997 No-Development-Reported for Cerebrovascular disorders in USA (Unknown route)
- 31 Aug 1995 Preclinical development for Cerebrovascular disorders in Japan (Unknown route)